SGEN vs STOK
SGEN (SGEN) versus Stoke Therapeutics Inc (STOK) — a side-by-side from cached financials, not a winner call.
SGEN (SGEN) common stock.
Stoke Therapeutics Inc (STOK) is a biotechnology company listed on NASDAQ.
SGEN does not have a complete income-statement cache yet.
Latest reported STOK revenue for 2026-06-30 was $15.6M. Net income was -$111.6M. STOK currently screens at market cap $1.88B.
STOK currently screens at market cap $1.88B.
Not investment advice. Open the SGEN and STOK stock pages for the full models.
Not investment advice.